Beamr video compression achieves up to 50% improvement for AVs
Investing.com -- Advanced Medical (TASE:BLWV) Solutions Group plc (LON:AMS (VIE:AMS2)) stock rose 3% after the company announced expectations for solid first-half 2025 financial results, with revenue projected at approximately £110 million.
The medical technology firm said it anticipates adjusted EBITDA of £24.0-24.5 million for the period. While consensus estimates weren’t available for the first half specifically, the company stated that performance "remains in line with expectations" and expressed confidence in meeting full-year targets.
Advanced Medical Solutions highlighted "strong underlying momentum" in its core surgical product portfolio. The integration of recent acquisitions Peters Surgical and Syntacoll is progressing well, according to the company.
The firm also completed the restructuring of its Wound Care business by the end of March, which has already resulted in improved margins for that segment beginning in the second quarter.
The company noted that full-year expectations imply an H2 weighting to both revenues and EBITDA, suggesting stronger performance in the latter half of 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.